CA2377780A1 - Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis - Google Patents

Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis Download PDF

Info

Publication number
CA2377780A1
CA2377780A1 CA002377780A CA2377780A CA2377780A1 CA 2377780 A1 CA2377780 A1 CA 2377780A1 CA 002377780 A CA002377780 A CA 002377780A CA 2377780 A CA2377780 A CA 2377780A CA 2377780 A1 CA2377780 A1 CA 2377780A1
Authority
CA
Canada
Prior art keywords
nucleic acid
oligonucleotide
dna
synthesis
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002377780A
Other languages
English (en)
French (fr)
Inventor
Mekbib Astatke
Deb Chatterjee
Gary Gerard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Invitrogen Corp
Life Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invitrogen Corp, Life Technologies Inc filed Critical Invitrogen Corp
Publication of CA2377780A1 publication Critical patent/CA2377780A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6848Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002377780A 1999-07-02 2000-06-30 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis Abandoned CA2377780A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14207299P 1999-07-02 1999-07-02
US60/142,072 1999-07-02
PCT/US2000/018256 WO2001002559A1 (en) 1999-07-02 2000-06-30 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis

Publications (1)

Publication Number Publication Date
CA2377780A1 true CA2377780A1 (en) 2001-01-11

Family

ID=22498453

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002377780A Abandoned CA2377780A1 (en) 1999-07-02 2000-06-30 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis

Country Status (8)

Country Link
EP (1) EP1196559B1 (https=)
JP (2) JP2003504018A (https=)
AT (1) ATE332371T1 (https=)
AU (1) AU782555B2 (https=)
CA (1) CA2377780A1 (https=)
DE (1) DE60029225T2 (https=)
NZ (1) NZ516894A (https=)
WO (1) WO2001002559A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002064833A1 (en) 2001-02-15 2002-08-22 Takara Bio Inc. Method of detecting nucleotide polymorphism
EP2330194A3 (en) * 2002-09-13 2011-10-12 Replicor, Inc. Non-sequence complementary antiviral oligonucleotides
EP1802774B1 (en) * 2004-10-18 2012-01-11 Brandeis University Reagents and methods for improving reproducibility and reducing mispriming in pcr amplification
WO2007038422A2 (en) 2005-09-26 2007-04-05 Allelogic Biosciences Corp. Oligonucleotides as temperature-sensitive inhibitors for dna polymerases
EP2458011B1 (en) 2005-10-03 2013-07-24 Life Technologies Corporation Compositions, methods, and kits for amplifying nucleic acids
US7781165B2 (en) 2005-10-19 2010-08-24 Roche Diagnostics Operations, Inc. Benzimidazolium compounds and salts of benzimidazolium compounds for nucleic acid amplification
JPWO2012070618A1 (ja) 2010-11-24 2014-05-19 株式会社カネカ 増幅核酸検出方法及び検出デバイス
WO2013154898A1 (en) * 2012-04-12 2013-10-17 Ong, Jennifer Synthetic nucleic acids for polymerization reactions
WO2013162026A1 (ja) * 2012-04-27 2013-10-31 株式会社カネカ 核酸の増幅方法、および、増幅核酸の検出方法
US10392652B2 (en) 2013-11-22 2019-08-27 Kaneka Corporation Micro RNA detection method using two primers to produce an amplified double stranded DNA fragment having a single stranded region at one end
JP7323534B2 (ja) * 2018-01-05 2023-08-08 ストラトス ゲノミクス インコーポレイテッド 芳香族化合物による核酸重合の強化
KR102275038B1 (ko) * 2019-12-11 2021-07-08 (주) 제노텍 대립 유전자의 구분성을 높이는 pcr 방법 및 pcr 킷트
JP2023531027A (ja) * 2020-06-22 2023-07-20 ▲蘇▼州新海生物科技股▲ふん▼有限公司 核酸リガンド、およびその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763173A (en) * 1990-06-11 1998-06-09 Nexstar Pharmaceuticals, Inc. Nucleic acid ligand inhibitors to DNA polymerases
DE69638318D1 (de) * 1995-06-07 2011-02-17 Gilead Sciences Inc Nukleinsäureliganden, die an DNA-Polymerasen binden und diese inhibieren
US5760012A (en) * 1996-05-01 1998-06-02 Thomas Jefferson University Methods and compounds for curing diseases caused by mutations

Also Published As

Publication number Publication date
DE60029225T2 (de) 2007-07-05
JP2003504018A (ja) 2003-02-04
AU782555B2 (en) 2005-08-11
AU5785000A (en) 2001-01-22
WO2001002559A1 (en) 2001-01-11
EP1196559B1 (en) 2006-07-05
WO2001002559A9 (en) 2002-07-25
JP2011041572A (ja) 2011-03-03
EP1196559A1 (en) 2002-04-17
NZ516894A (en) 2004-06-25
DE60029225D1 (de) 2006-08-17
ATE332371T1 (de) 2006-07-15

Similar Documents

Publication Publication Date Title
US8043816B2 (en) Compositions and methods for temperature-dependent nucleic acid synthesis
US5739311A (en) Enzymatic synthesis of phosphorothioate oligonucleotides using restriction endonucleases
JP2011041572A (ja) 核酸合成の感度および特異性の増大のための組成物および方法
US5932450A (en) Enzymatic synthesis of oligonucleotides using digestible templates
US5512462A (en) Methods and reagents for the polymerase chain reaction amplification of long DNA sequences
US5916777A (en) Enzymatic synthesis of oligonucleotides using 3'-ribonucleotide primers
JPH04507197A (ja) 増強された核酸増幅方法
JPWO2000056877A1 (ja) 核酸配列の増幅方法
JP2003535587A (ja) 低温感受性変異体dnaポリメラーゼ
JPH10510161A (ja) 末端反復増幅方法
EP1132470A1 (en) METHOD FOR SYNTHESIZING cDNA
EP0747479A1 (en) Template and primer based synthesis of enzymatically cleavable oligonucleotides
US8058032B2 (en) Method for amplifying unknown DNA sequence adjacent to known sequence
US5652126A (en) Use of restriction endonuclease sequences for cleaving phosphorothioate oligonucleotides
EP0598832A4 (en) Dna sequencing with a t7-type gene 6 exonuclease.
CA2421391A1 (en) Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
KR100454172B1 (ko) Dna 증폭방법 및 그의 키트
WO2000020630A1 (en) Oligonucleotide primers that destabilize non-specific duplex formation and uses thereof
Zarlenga cDNA Cloning and the Construction of Recombinant DNA
JPWO1999009213A1 (ja) Dna増幅方法及びそのキット
EP1548113A1 (en) A method for obtaining circular mutated and/or chimaeric polynucleotides
CA2346146A1 (en) Oligonucleotide primers that destabilize non-specific duplex formation and uses thereof

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued